Chief Legal Officer · Immuneering Corp (IMRX)

Michael Bookman

A named executive officer of Immuneering in every fiscal year CompBrief holds from FY2024 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$890,362

FY2024: $1,088,351

3rd of 3 named executive officers at Immuneering by FY2025 total.

3 named officers on file for Immuneering, FY2025

See an example →

What this number hides

The filing gives the total. Immuneering’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Immuneering’s whole pay program stands against its peers

  • Immuneering’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IMRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 20, 2026 (DEF 14A).

Free

Get Michael Bookman’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Michael Bookman and every company like it: Velarion Intel, free for 3 days, no card →

Michael Bookman compensation by year

Immuneering Summary Compensation Table · all 2 fiscal years held
In US dollars, as Immuneering reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024FY2025
Salary$482,778$502,089
Bonus$193,111$241,003
Stock awards$0$0
Option awards$398,393$132,803
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$14,070$14,468
Total$1,088,351$890,362

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Immuneering Corp DEF 14A filed April 20, 2026, accession 0001790340-26-000048, and prior-year filings.

How this page was built: the Immuneering Corp filed document, accession 0001790340-26-000048. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2026.

$1.1M
$890K
FY24
FY25
SalaryBonusOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option48,438—$3.01
Option986—$3.01
Option38,730—$3.01
Option84,792—$1.91

Per the Outstanding Equity Awards at Fiscal Year-End table in Immuneering Corp's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Immuneering’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Benjamin ZeskindPresident and Chief Executive Officer$1,660,612
Brett HallChief Scientific Officer$1,289,504
Michael Bookman · this pageChief Legal Officer$890,362

Michael Bookman's compensation dossier, Immuneering

You have read Michael Bookman's totals and holdings. The dossier adds each equity grant Immuneering disclosed for Michael Bookman and Immuneering's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Immuneering compensation record

free company brief

This page is one person within Immuneering's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Immuneering's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Immuneering's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Bookman's compensation dossier